Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4a and Cdk2/Cyclin E complex activation

被引:171
|
作者
Suzuki, A
Hayashida, M
Ito, T
Kawano, H
Nakano, T
Miura, M
Akahane, K
Shiraki, K
机构
[1] Daiichi Pharmaceut Co Ltd, Basic Technol Res Lab, Project Cell Death Res, Tokyo R&D Ctr,Edogawa Ku, Tokyo 1348630, Japan
[2] Mie Univ, Dept Internal Med 1, Sch Med, Tsu, Mie 5148507, Japan
[3] Osaka Univ, Sch Med, Biomed Res Ctr, Dept Neuroanat, Suita, Osaka 565, Japan
[4] Daiichi Pharmaceut Co Ltd, New Prod Res Labs 4, Tokyo R&D Ctr, Edogawa Ku, Tokyo 1348630, Japan
关键词
Survivin; Cdk; INK4a; p27; cell cycle progression;
D O I
10.1038/sj.onc.1203665
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Survivin is observed uniquely in tumor cells and developmental cells, which undergo either inappropriate or programmed cell growth, In the current study, we investigated the influence of Survivin on cell cycle, Overexpression of Survivin resulted in accelerated S phase shift, resistance to G1 arrest, and activated Cdk2/Cyclin E complex leading Rb phosphorylation, In addition, nuclear translocation of Survivin followed by an interaction with Cdk4 was detected. Interestingly, Survivin nuclear translocation coincided with S phase shift, and prevention of nuclear transport suppressed Survivin nuclear translocation and S phase shift. Further, we also observed that Survivin competitively interacted with the Cdk4/p16(INK4n) complex in a cell free system and in vivo. These results suggest that Survivin initiates the cell cycle entry as a result of nuclear translocation followed by an interaction with Cdk4.
引用
收藏
页码:3225 / 3234
页数:10
相关论文
共 50 条
  • [1] Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16INK4a and Cdk2/Cyclin E complex activation
    Atsushi Suzuki
    Midori Hayashida
    Takeshi Ito
    Hirokazu Kawano
    Takeshi Nakano
    Masayuki Miura
    Kouichi Akahane
    Katsuya Shiraki
    [J]. Oncogene, 2000, 19 : 3225 - 3234
  • [2] Theory Slower CDK4 and faster CDK2 activation in the cell cycle
    Zhang, Wengang
    Liu, Yonglan
    Jang, Hyunbum
    Nussinov, Ruth
    [J]. STRUCTURE, 2024, 32 (08)
  • [3] Phosphorylation of p16INK4A correlates with Cdk4 association
    Gump, J
    Stokoe, D
    McCormick, F
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (09) : 6619 - 6622
  • [4] Deciphering the activation mechanism of CDK4/cyclin-D complex that differs from the CDK2/cyclin-E complex
    Zhang, Wengang
    Liu, Yonglan
    Zhang, Mingzhen
    Jang, Hyunbum
    Nussinov, Ruth
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [5] p16INK4a abrogation by a mutant cyclin dependent kinase 4 (CDK4) changes CML kinetics
    Chinswangwatanakul, W
    Lewis, JL
    Marley, SB
    Cross, NCP
    Goldman, JM
    Gordon, MY
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 276 - 277
  • [6] Caenorhabditis elegans Cyclin D/CDK4 and Cyclin E/CDK2 Induce Distinct Cell Cycle Re-Entry Programs in Differentiated Muscle Cells
    Korzelius, Jerome
    The, Inge
    Ruijtenberg, Suzan
    Prinsen, Martine B. W.
    Portegijs, Vincent
    Middelkoop, Teije C.
    Koerkamp, Marian J. Groot
    Holstege, Frank C. P.
    Boxem, Mike
    van den Heuvel, Sander
    [J]. PLOS GENETICS, 2011, 7 (11):
  • [7] Mutual requirement of CDK4 and Myc in malignant transformation: evidence for cyclin D1/CDK4 and p16INK4A as upstream regulators of Myc
    Kirsten Haas
    Peter Staller
    Christoph Geisen
    Jiri Bartek
    Martin Eilers
    Tarik Möröy
    [J]. Oncogene, 1997, 15 : 179 - 192
  • [8] The p16INK4A protein and flavopiridol restore yeast cell growth inhibited by Cdk4
    Moorthamer, M
    Panchal, M
    Greenhalf, W
    Chaudhuri, B
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 250 (03) : 791 - 797
  • [9] Induction of urothelial proliferation in rats by aristolochic acid through cell cycle progression via activation of cyclin D1/cdk4 and cyclin E/cdk2
    Chang, HR
    Lian, JD
    Lo, CW
    Chang, YC
    Yang, MY
    Wang, CJ
    [J]. FOOD AND CHEMICAL TOXICOLOGY, 2006, 44 (01) : 28 - 35
  • [10] A CDKN2A mutation in familial melanoma that abrogates binding of p16INK4a to CDK4 but not CDK6
    Jones, Rebecca
    Ruas, Margarida
    Gregory, Fiona
    Moulin, Stephanie
    Delia, Domenico
    Manoukian, Siranoush
    Rowe, Janice
    Brookes, Sharon
    Peters, Gordon
    [J]. CANCER RESEARCH, 2007, 67 (19) : 9134 - 9141